Geron (GERN) Cash from Investing Activities (2010 - 2026)

Geron's (GERN) quarterly Cash from Investing Activities came in at $51.9 million in Q1 2026, down 1.11% year-on-year from $52.4 million in Q1 2025, and up 145.24% quarter-over-quarter from $21.1 million in Q4 2025.

Geron (GERN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Geron has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $51.9 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $51.9 million, down 1.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.7 million (up 221.52% YoY), and the FY2025 annual result was $107.2 million, up 201.17% from the prior year.
  • Cash from Investing Activities came in at $51.9 million for Q1 2026 at Geron, up from $21.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $52.4 million in Q1 2025 to a low of -$178.7 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is $13.3 million (2025), against an average of -$3.8 million.
  • Across the five-year window, Cash from Investing Activities sank 1681.64% in 2023 and soared 2509.39% in 2025, its largest moves.
  • Geron's Cash from Investing Activities stood at $19.0 million in 2022, then surged by 150.52% to $47.6 million in 2023, then slumped by 317.6% to -$103.5 million in 2024, then soared by 120.43% to $21.1 million in 2025, then jumped by 145.24% to $51.9 million in 2026.
  • The last three Cash from Investing Activities figures came in at $51.9 million (Q1 2026), $21.1 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.89 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 579,519.10
10 Geron 729,618.77 729,618.77 - 51.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.86 Mn
Mar 31, 2026 51.86 Mn
Dec 31, 2025 21.15 Mn
Dec 31, 2025 21.15 Mn
Sep 30, 2025 13.35 Mn
Sep 30, 2025 13.35 Mn
Jun 30, 2025 20.32 Mn
Jun 30, 2025 20.32 Mn
Mar 31, 2025 52.44 Mn
Mar 31, 2025 52.44 Mn
Dec 31, 2024 -103.51 Mn
Dec 31, 2024 -103.51 Mn
Sep 30, 2024 -554,000.00
Sep 30, 2024 -554,000.00
Jun 30, 2024 -36.15 Mn
Jun 30, 2024 -36.15 Mn
Mar 31, 2024 34.21 Mn
Mar 31, 2024 34.21 Mn
Dec 31, 2023 47.57 Mn
Dec 31, 2023 47.57 Mn